US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 3.910
  • -0.360-8.43%
Close Mar 24 16:00 ET
95.26MMarket Cap-1.45P/E (TTM)

Artiva Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-99.25%251K
0
0
0
-74.62%251K
579.21%33.49M
2.35M
26.66M
0
-26.63%989K
Operating revenue
--0
--0
--0
--0
--0
567.67%32.92M
--1.78M
--26.66M
--0
-26.63%989K
Cost of revenue
Gross profit
Operating expense
5.25%67.53M
27.56%18.27M
15.71%18.34M
5.67%16.19M
-21.06%14.74M
-0.92%64.16M
14.32M
15.85M
15.32M
38.64%18.68M
Selling and administrative expenses
23.67%17.21M
56.30%4.95M
73.06%4.81M
-4.98%3.86M
-8.17%3.59M
-33.04%13.91M
--3.17M
--2.78M
--4.06M
3.69%3.91M
-General and administrative expense
23.67%17.21M
56.30%4.95M
73.06%4.81M
-4.98%3.86M
-8.17%3.59M
-33.04%13.91M
--3.17M
--2.78M
--4.06M
3.69%3.91M
Research and development costs
0.15%50.33M
19.40%13.32M
3.51%13.52M
9.51%12.33M
-24.47%11.16M
14.25%50.25M
--11.15M
--13.07M
--11.26M
52.20%14.77M
Operating profit
-119.37%-67.28M
-52.61%-18.27M
-269.60%-18.34M
-5.67%-16.19M
18.07%-14.49M
48.74%-30.67M
-11.97M
10.81M
-15.32M
-45.89%-17.69M
Net non-operating interest income expense
111.01%5.35M
273.41%2.18M
341.63%1.85M
-32.81%-676K
-36.52%650K
95.90%2.54M
583K
418K
-509K
1.02M
Non-operating interest income
111.01%5.35M
273.41%2.18M
341.63%1.85M
-32.81%-676K
-36.52%650K
95.90%2.54M
--583K
--418K
---509K
--1.02M
Other net income (expense)
-771.88%-3.44M
-101.03%-5K
-2,066.00%-983K
7,612.90%2.33M
-128.30%-121K
156.00%512K
485K
50K
-31K
-53K
Gain on sale of security
-608.77%-3.6M
--0
---977K
--2.35M
---268K
--707K
----
----
----
----
Other non- operating income (expenses)
180.51%157K
97.75%-5K
-112.00%-6K
25.81%-23K
377.36%147K
-197.50%-195K
---222K
--50K
---31K
---53K
Income before tax
-136.65%-65.37M
-47.63%-16.1M
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.65%-27.62M
-10.9M
11.28M
-15.86M
-37.88%-16.72M
Income tax
0
35.85%72K
Net income
-136.04%-65.37M
-46.66%-16.1M
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
-10.97M
11.28M
-15.86M
-37.88%-16.72M
Net income continuous Operations
-136.04%-65.37M
-46.66%-16.1M
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
---10.97M
--11.28M
---15.86M
-37.88%-16.72M
Minority interest income
Net income attributable to the parent company
-136.04%-65.37M
-46.66%-16.1M
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
-10.97M
11.28M
-15.86M
-37.88%-16.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-136.04%-65.37M
-46.66%-16.1M
-254.91%-17.47M
8.35%-14.54M
16.47%-13.96M
52.57%-27.7M
-10.97M
11.28M
-15.86M
-37.88%-16.72M
Basic earnings per share
-89.25%-5.81
-40.58%-0.6626
-176.36%-0.92
63.15%-0.6244
16.56%-1.49
50.78%-3.07
-0.4714
1.2048
-1.6943
-37.88%-1.7857
Diluted earnings per share
-89.25%-5.81
-40.58%-0.6626
-176.36%-0.92
63.15%-0.6244
16.56%-1.49
50.78%-3.07
-0.4714
1.2048
-1.6943
-37.88%-1.7857
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -99.25%251K000-74.62%251K579.21%33.49M2.35M26.66M0-26.63%989K
Operating revenue --0--0--0--0--0567.67%32.92M--1.78M--26.66M--0-26.63%989K
Cost of revenue
Gross profit
Operating expense 5.25%67.53M27.56%18.27M15.71%18.34M5.67%16.19M-21.06%14.74M-0.92%64.16M14.32M15.85M15.32M38.64%18.68M
Selling and administrative expenses 23.67%17.21M56.30%4.95M73.06%4.81M-4.98%3.86M-8.17%3.59M-33.04%13.91M--3.17M--2.78M--4.06M3.69%3.91M
-General and administrative expense 23.67%17.21M56.30%4.95M73.06%4.81M-4.98%3.86M-8.17%3.59M-33.04%13.91M--3.17M--2.78M--4.06M3.69%3.91M
Research and development costs 0.15%50.33M19.40%13.32M3.51%13.52M9.51%12.33M-24.47%11.16M14.25%50.25M--11.15M--13.07M--11.26M52.20%14.77M
Operating profit -119.37%-67.28M-52.61%-18.27M-269.60%-18.34M-5.67%-16.19M18.07%-14.49M48.74%-30.67M-11.97M10.81M-15.32M-45.89%-17.69M
Net non-operating interest income expense 111.01%5.35M273.41%2.18M341.63%1.85M-32.81%-676K-36.52%650K95.90%2.54M583K418K-509K1.02M
Non-operating interest income 111.01%5.35M273.41%2.18M341.63%1.85M-32.81%-676K-36.52%650K95.90%2.54M--583K--418K---509K--1.02M
Other net income (expense) -771.88%-3.44M-101.03%-5K-2,066.00%-983K7,612.90%2.33M-128.30%-121K156.00%512K485K50K-31K-53K
Gain on sale of security -608.77%-3.6M--0---977K--2.35M---268K--707K----------------
Other non- operating income (expenses) 180.51%157K97.75%-5K-112.00%-6K25.81%-23K377.36%147K-197.50%-195K---222K--50K---31K---53K
Income before tax -136.65%-65.37M-47.63%-16.1M-254.91%-17.47M8.35%-14.54M16.47%-13.96M52.65%-27.62M-10.9M11.28M-15.86M-37.88%-16.72M
Income tax 035.85%72K
Net income -136.04%-65.37M-46.66%-16.1M-254.91%-17.47M8.35%-14.54M16.47%-13.96M52.57%-27.7M-10.97M11.28M-15.86M-37.88%-16.72M
Net income continuous Operations -136.04%-65.37M-46.66%-16.1M-254.91%-17.47M8.35%-14.54M16.47%-13.96M52.57%-27.7M---10.97M--11.28M---15.86M-37.88%-16.72M
Minority interest income
Net income attributable to the parent company -136.04%-65.37M-46.66%-16.1M-254.91%-17.47M8.35%-14.54M16.47%-13.96M52.57%-27.7M-10.97M11.28M-15.86M-37.88%-16.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -136.04%-65.37M-46.66%-16.1M-254.91%-17.47M8.35%-14.54M16.47%-13.96M52.57%-27.7M-10.97M11.28M-15.86M-37.88%-16.72M
Basic earnings per share -89.25%-5.81-40.58%-0.6626-176.36%-0.9263.15%-0.624416.56%-1.4950.78%-3.07-0.47141.2048-1.6943-37.88%-1.7857
Diluted earnings per share -89.25%-5.81-40.58%-0.6626-176.36%-0.9263.15%-0.624416.56%-1.4950.78%-3.07-0.47141.2048-1.6943-37.88%-1.7857
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
278.390
Advanced Micro Devices
AMD
113.850
Meta Platforms
META
618.850
4
Amazon
AMZN
203.260
5
NVIDIA
NVDA
121.410
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings